159 related articles for article (PubMed ID: 3291371)
1. Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial.
Murphy GP; Priore RL; Scardino PT
Urology; 1988 Jul; 32(1):33-40. PubMed ID: 3291371
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
Herr HW
J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study.
Wozniak AJ; Blumenstein BA; Crawford ED; Boileau M; Rivkin SE; Fletcher WS
Cancer; 1993 Jun; 71(12):3975-8. PubMed ID: 8508363
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
[TBL] [Abstract][Full Text] [Related]
6. Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivation.
Hickey D; Cant J; Soloway MS
Urology; 1988 Jan; 31(1):38-40. PubMed ID: 2447693
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic agents effective in prostate cancer.
Schmidt JD
Semin Urol; 1983 Nov; 1(4):299-310. PubMed ID: 6399616
[No Abstract] [Full Text] [Related]
8. Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study.
Saxman S; Ansari R; Drasga R; Miller M; Wheeler B; McClean J; Einhorn L
Cancer; 1992 Nov; 70(10):2488-92. PubMed ID: 1423178
[TBL] [Abstract][Full Text] [Related]
9. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
Graham SD; Walker A; Cox EB; Laszlo J; Berry WR; Paulson DF
Urology; 1986 Nov; 28(5):404-8. PubMed ID: 3538611
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
[TBL] [Abstract][Full Text] [Related]
11. Hexamethylmelamine, methotrexate and 5-fluorouracil (HMF) for progressive ovarian carcinoma during therapy with cis-platinum, cyclophosphamide +/- doxorubicin.
Carlson JA; Day TG; Botts B; Masterson BJ
Gynecol Oncol; 1985 Oct; 22(2):189-94. PubMed ID: 3932141
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
13. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
[TBL] [Abstract][Full Text] [Related]
14. [Treatment for hormone-refractory or relapsing prostatic cancer].
Hirao Y; Ozono S; Okajima E
Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492
[TBL] [Abstract][Full Text] [Related]
15. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
[TBL] [Abstract][Full Text] [Related]
16. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
[TBL] [Abstract][Full Text] [Related]
17. [Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients].
Salzer H; Gitsch E; Dittrich C; Sevelda P; Karrer K; Schemper M; Stempel-Smekal G; Langer M; Wagner G; Rainer H
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):761-8. PubMed ID: 3908214
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cyclophosphamide, adriamycin, and cis-platinum (CAP) in patients with disseminated prostatic carcinoma. A phase II study.
Drelichman A; Oldford J; Al-Sarraf M
Am J Clin Oncol; 1985 Jun; 8(3):255-9. PubMed ID: 3840326
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy principles in the treatment of prostatic cancer.
Könyves I; Müntzing J; Rozencweig M
Prostate; 1984; 5(1):55-62. PubMed ID: 6364076
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
